Additional Information
Book Details
Abstract
Building on established diagnostic techniques, Essentials of Internal Medicine 3e presents a modern approach to internal medicine, equipping the reader with the skills to become an effective internist.
This text presents practical approaches to diagnosis and up to date strategies for implementing evidence-based treatments for prevalent conditions.
Learn how to:
- Identify what is clinically important
- Understand and investigate disease
- Create an effective strategy for treatment
- Utilize technological diagnostic tools now available
- Color illustrations to enhance recognition and learning
- Clinical pearls
- Memory jog lists and tables
- Multiple choice questions with answers and explanations
Content has been organized around themes of:
- Holistic approach to patient treatment
- The importance of diagnosis
- The physician’s role in public health
- The physician as scholar
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| Essentials of Internal Medicine | iii | ||
| Copyright Page | iv | ||
| Table of Contents | vii | ||
| FOREWORD BY KENNETH DEVAULT | v | ||
| FOREWORD BY NICHOLAS SAUNDERS | vi | ||
| PREFACE | xxi | ||
| CONTRIBUTORS | xxii | ||
| REVIEWERS | xxiv | ||
| CHAPTER 1. INTERNAL MEDICINE IN THE 21st CENTURY—BEST PRACTICE, BEST OUTCOMES | 1 | ||
| GENERAL VERSUS SUB-SPECIALTY MEDICINE | 1 | ||
| THE IMPORTANCE OF DIAGNOSIS | 2 | ||
| THE PHYSICIAN’S ROLE IN PUBLIC HEALTH | 2 | ||
| THE PHYSICIAN AS SCHOLAR | 2 | ||
| CHAPTER 2. EVIDENCE-BASED MEDICINE AND CRITICAL APPRAISAL OF THE LITERATURE | 5 | ||
| INTRODUCTION | 5 | ||
| ASSESSING THE EVIDENCE | 5 | ||
| CRITICAL APPRAISAL OF THE LITERATURE | 8 | ||
| INTERPRETING A STUDY’S FINDINGS | 9 | ||
| INTERPRETING STATISTICAL ANALYSIS | 10 | ||
| INTERPRETING TEST RESULTS | 11 | ||
| SCREENING | 13 | ||
| CONCLUSION | 13 | ||
| ACKNOWLEDGMENTS | 13 | ||
| SELF-ASSESSMENT QUESTIONS | 14 | ||
| CHAPTER 3. ETHICS | 17 | ||
| ETHICS IN INTERNAL MEDICINE | 17 | ||
| ETHICAL THEORIES | 18 | ||
| ETHICS AND THE LAW | 18 | ||
| ETHICS, EVIDENCE AND DECISION-MAKING | 18 | ||
| CLINICAL ETHICS: THEORY AND FRAMEWORKS FOR DECISION-MAKING | 19 | ||
| TEACHING ABOUT ETHICS | 19 | ||
| PHYSICIAN–PATIENT RELATIONSHIPS AND PROFESSIONALISM | 19 | ||
| TRUTH-TELLING | 19 | ||
| CONFIDENTIALITY | 20 | ||
| CONSENT | 21 | ||
| MENTAL COMPETENCE | 21 | ||
| END-OF-LIFE AND FUTILITY | 22 | ||
| DIGNITY AND THE CARE OF THE ELDERLY | 22 | ||
| CONFLICT OF INTEREST AND THE PHARMACEUTICAL INDUSTRY | 23 | ||
| References | 23 | ||
| SELF-ASSESSMENT QUESTIONS | 24 | ||
| CHAPTER 4. CLINICAL PHARMACOLOGY AND TOXICOLOGY | 27 | ||
| 1. PRINCIPLES OF CLINICAL PHARMACOLOGY | 28 | ||
| INTRODUCTION | 28 | ||
| PHARMACOKINETICS | 29 | ||
| PHARMACODYNAMICS | 34 | ||
| THE INNOCENT BYSTANDER | 36 | ||
| 2. QUALITY USE OF MEDICINES | 36 | ||
| GETTING IT RIGHT | 37 | ||
| PRESCRIBING | 37 | ||
| DEPRESCRIBING | 38 | ||
| ADVERSE DRUG REACTIONS | 38 | ||
| DRUG INTERACTIONS | 39 | ||
| THERAPEUTIC DRUG MONITORING (TDM) | 40 | ||
| DRUG REGULATION | 40 | ||
| DRUG RESEARCH | 41 | ||
| 3. TOXICOLOGY | 42 | ||
| EPIDEMIOLOGY OF POISONING | 42 | ||
| SOURCES OF POISONS INFORMATION AND ADVICE | 42 | ||
| CLINICAL ASSESSMENT OF POISONED PATIENTS | 42 | ||
| PRINCIPLES OF MANAGEMENT OF POISONED PATIENTS | 43 | ||
| COMMON POISONS AND THEIR MANAGEMENT | 44 | ||
| DRUGS OF ABUSE OR MISUSE | 47 | ||
| CHEMICALS | 49 | ||
| SPIDER BITES | 49 | ||
| SNAKE BITES | 50 | ||
| MARINE ENVENOMATION | 50 | ||
| TERRORISM, AND USE OF MEDICAL COUNTERMEASURES | 51 | ||
| SELF-ASSESSMENT QUESTIONS | 53 | ||
| CHAPTER 5. GENETICS | 57 | ||
| OVERVIEW | 57 | ||
| THE FLOW OF GENETICINFORMATION | 58 | ||
| GENETIC VARIATION | 61 | ||
| MENDELIAN DISEASES | 62 | ||
| CALCULATING THE RISKSOF DISEASE | 63 | ||
| GENETIC TESTING INMEDICINE | 64 | ||
| COMMON CHROMOSOMAL GENETIC CONDITIONS | 65 | ||
| ACKNOWLEDGMENTS | 66 | ||
| SELF-ASSESSMENT QUESTIONS | 67 | ||
| CHAPTER 6. MEDICAL IMAGING FOR INTERNISTS | 71 | ||
| 1. CHEST RADIOGRAPHY | 72 | ||
| PRINCIPLES OFINTERPRETATION IN CHEST X-RAYS | 72 | ||
| 2. THORACIC COMPUTEDTOMOGRAPHY | 80 | ||
| TECHNIQUES OF EXAMINATION | 80 | ||
| PRINCIPLES OF INTERPRETATION IN CHEST CT | 80 | ||
| 3. ABDOMINAL COMPUTED TOMOGRAPHY | 85 | ||
| TECHNIQUES OF EXAMINA | 85 | ||
| PRINCIPLES OF INTERPRETATION IN ABDOMINAL CT | 86 | ||
| 4. ABDOMINAL ULTRASOUND | 90 | ||
| BACKGROUND—ULTRASOUND PRINCIPLES | 90 | ||
| PRINCIPLES OF ULTRASOUND INTERPRETATION | 91 | ||
| LOWER LIMB DUPLEX ULTRASOUND | 93 | ||
| 5. HEAD COMPUTED TOMOGRAPHY | 94 | ||
| CT BRAIN PROTOCOLS | 94 | ||
| PRINCIPLES OF INTERPRETATION IN BRAIN CT | 95 | ||
| 6. HEAD MAGNETIC RESONANCE | 101 | ||
| MRI PROTOCOLS | 102 | ||
| PRINCIPLES OF INTERPRETATION IN BRAIN MR | 107 | ||
| 7. POSITRON EMISSION TOMOGRAPHY (PET) | 111 | ||
| CHAPTER 7. PULMONOLOGY | 113 | ||
| 1. PULMONARY MEDICINE | 114 | ||
| CLINICAL PRESENTATIONS OF RESPIRATORY DISEASE | 114 | ||
| IMPORTANT CLINICAL CLUES | 114 | ||
| OVERVIEW OF THE RESPIRATORY SYSTEM AND PATHOPHYSIOLOGY | 118 | ||
| ACID–BASE DISTURBANCES FROM A PULMONARY PERSPECTIVE | 120 | ||
| MEASUREMENT OF LUNG FUNCTION | 120 | ||
| CONTROL OF BREATHING | 122 | ||
| RESPIRATORY TRACT DEFENSES | 122 | ||
| GENETICS OF LUNG DISEASE | 124 | ||
| PULMONARY DISORDERS | 124 | ||
| DISEASES OF THE AIRWAYS | 124 | ||
| EOSINOPHILIC PULMONARY DISORDERS | 133 | ||
| PULMONARY HEMORRHAGE | 133 | ||
| PULMONARY INFECTIONS | 134 | ||
| PLEURAL DISEASE | 136 | ||
| PNEUMOTHORAX | 138 | ||
| PULMONARY VASCULAR DISEASE | 138 | ||
| LUNG TRANSPLANTATION | 140 | ||
| PHARMACOLOGY | 141 | ||
| RESPIRATORY SLEEP MEDICINE | 142 | ||
| 2. CRITICAL CARE MEDICINE | 144 | ||
| RESUSCITATION | 144 | ||
| DIAGNOSIS AND DISEASE MANAGEMENT | 144 | ||
| MECHANICAL VENTILATION OF THE LUNGS | 147 | ||
| SELF-ASSESSMENT QUESTIONS | 150 | ||
| CHAPTER 8. CARDIOLOGY | 153 | ||
| CLINICAL EVALUATION OF THE PATIENT | 154 | ||
| INVESTIGATION OF CARDIAC DISEASE | 160 | ||
| DYSLIPIDEMIA | 168 | ||
| CORONARY ARTERY DISEASE (CAD) | 172 | ||
| STABLE CORONARY ARTERY DISEASE | 172 | ||
| ACUTE CORONARY SYNDROMES | 177 | ||
| VALVULAR HEART DISEASE | 181 | ||
| MITRAL VALVE DISEASE | 182 | ||
| AORTIC VALVE DISEASE | 185 | ||
| TRICUSPID VALVE DISEASE | 188 | ||
| PULMONARY VALVE DISEASE | 189 | ||
| CARDIOMYOPATHIES | 190 | ||
| CARDIAC ARRHYTHMIAS | 194 | ||
| CONDUCTION DEFECTS | 201 | ||
| CARDIAC FAILURE | 203 | ||
| INFECTIVE ENDOCARDITIS | 208 | ||
| PERICARDIAL DISEASES | 211 | ||
| SELF-ASSESSMENT QUESTIONS | 214 | ||
| CHAPTER 9. HYPERTENSION | 217 | ||
| MECHANISMS OF HYPERTENSION | 217 | ||
| EPIDEMIOLOGICAL EVIDENCE FOR HYPERTENSION AND ITS EFFECTS | 218 | ||
| DEFINITIONS OF HYPERTENSION | 220 | ||
| CLINICAL PRESENTATIONS AND INVESTIGATIONS | 221 | ||
| TARGET-ORGAN EFFECTS OF HYPERTENSION | 222 | ||
| TREATMENT AND TARGETS FOR HYPERTENSION CONTROL | 224 | ||
| TREATMENT FOR CHRONIC PRIMARY HYPERTENSION | 225 | ||
| TREATMENT IN AN ACUTE SETTING | 226 | ||
| SELF-ASSESSMENT QUESTIONS | 228 | ||
| CHAPTER 10. NEPHROLOGY | 231 | ||
| INHERITED CYSTIC KIDNEY DISEASE | 232 | ||
| ACQUIRED KIDNEY CYSTIC DISEASE | 234 | ||
| KIDNEY AND URINARY TRACT INFECTION | 238 | ||
| INHERITED RENAL BASEMENT MEMBRANE DISEASE | 238 | ||
| GLOMERULONEPHRITIS (GN) | 239 | ||
| SCLEROSING GLOMERULAR DISEASE | 248 | ||
| VASCULAR RENAL DISEASE | 251 | ||
| THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)/HEMOLYTIC UREMIC SYNDROME (HUS) | 251 | ||
| MALIGNANT HYPERTENSION | 252 | ||
| SCLERODERMA KIDNEY | 252 | ||
| REFLUX NEPHROPATHY | 253 | ||
| CHRONIC KIDNEY DISEASE (CKD) | 253 | ||
| ACUTE RENAL FAILURE—ACUTE KIDNEY INJURY (AKI) | 257 | ||
| TUBULO-INTERSTITIAL DISEASES | 257 | ||
| ELECTROLYTE DISORDERS | 258 | ||
| INHERITED ‘CHANNELOPATHIES’ ASSOCIATED WITH HYPERTENSION OR HYPERKALEMIA | 261 | ||
| THE KIDNEYS IN PREGNANCY AND PREGNANCY-RELATED DISEASES | 262 | ||
| SELF-ASSESSMENT QUESTIONS | 264 | ||
| CHAPTER 11. ENDOCRINOLOGY | 267 | ||
| SYSTEM OVERVIEW | 268 | ||
| DISORDERS OF THE PITUITARY AND HYPOTHALAMUS | 270 | ||
| THYROID DISORDERS | 275 | ||
| DISORDERS OF BONE AND MINERAL METABOLISM | 281 | ||
| ADRENAL DISORDERS | 287 | ||
| GROWTH AND PUBERTY | 294 | ||
| MALE REPRODUCTIVE ENDOCRINOLOGY | 295 | ||
| FEMALE REPRODUCTIVE ENDOCRINOLOGY | 298 | ||
| NEUROENDOCRINE TUMORS (NETs) | 300 | ||
| DISORDERS OF MULTIPLE ENDOCRINE SYSTEMS | 302 | ||
| DIABETES AND METABOLISM | 303 | ||
| SELF-ASSESSMENT QUESTIONS | 315 | ||
| CHAPTER 12. GASTROENTEROLOGY | 319 | ||
| ESOPHAGUS | 320 | ||
| STOMACH | 323 | ||
| SMALL BOWEL | 327 | ||
| NUTRITIONAL DEFICIENCY | 338 | ||
| LARGE BOWEL | 342 | ||
| BOWEL CANCER SCREENING | 353 | ||
| GASTROINTESTINAL BLEEDING | 355 | ||
| PANCREAS | 358 | ||
| SELF-ASSESSMENT QUESTIONS | 364 | ||
| CHAPTER 13. HEPATOLOGY | 371 | ||
| LIVER FUNCTION TESTS AND THEIR ABNORMALITIES | 372 | ||
| APPROACH TO THE PATIENT WITH LIVER DISEASE | 372 | ||
| BILIRUBIN METABOLISM AND JAUNDICE | 374 | ||
| VIRAL HEPATITIS | 377 | ||
| CIRRHOSIS | 383 | ||
| ASCITES | 385 | ||
| HEPATORENAL SYNDROME (HRS) | 387 | ||
| HYPONATREMIA | 387 | ||
| SPONTANEOUS BACTERIAL PERITONITIS (SBP) | 388 | ||
| PORTAL HYPERTENSIVE BLEEDING | 388 | ||
| PORTOSYSTEMIC ENCEPHALOPATHY (PSE) | 389 | ||
| PORTOPULMONARY HYPERTENSION (POPH) | 391 | ||
| HEPATOPULMONARY SYNDROME (HPS) | 391 | ||
| CIRRHOTIC CARDIOMYOPATHY | 392 | ||
| ACUTE LIVER FAILURE (ALF) | 392 | ||
| LIVER TRANSPLANTATION | 393 | ||
| DRUGS AND THE LIVER | 394 | ||
| ALCOHOL AND THE LIVER | 394 | ||
| SPECIFIC LIVER DISEASES | 396 | ||
| AUTOIMMUNE LIVER DISEASES | 398 | ||
| SYSTEMIC DISEASE AND THE LIVER | 400 | ||
| PREGNANCY AND LIVER DISEASE | 400 | ||
| GALLBLADDER AND BILIARY TREE | 400 | ||
| PORPHYRIAS | 401 | ||
| SELF-ASSESSMENT QUESTIONS | 402 | ||
| CHAPTER 14. HEMATOLOGY | 407 | ||
| HEMOSTASIS | 408 | ||
| VENOUS THROMBOSIS | 410 | ||
| ANTIPHOSPHOLIPID SYNDROME (APS) | 412 | ||
| THROMBOSIS AT UNUSUALSITES | 413 | ||
| CANCER AND THROMBOSIS | 413 | ||
| BLEEDING DISORDERS | 414 | ||
| PLATELET DISORDERS | 417 | ||
| DISSEMINATED INTRAVASCULAR COAGULATION (DIC) | 419 | ||
| COAGULOPATHY IN INTENSIVE CARE PATIENTS | 421 | ||
| MYELOPROLIFERATIVE DISORDERS | 421 | ||
| LEUKEMIA | 426 | ||
| NON- HODGKIN LYMPHOMAS | 434 | ||
| HODGKIN LYMPHOMA (HL) | 436 | ||
| PLASMA CELL DISORDERS | 438 | ||
| ANEMIA | 440 | ||
| SELF- ASSESSMENT QUESTIONS | 451 | ||
| CHAPTER 15. ONCOLOGY | 455 | ||
| WHAT IS CANCER? | 457 | ||
| PREVENTION | 457 | ||
| DIAGNOSIS | 458 | ||
| PROGNOSIS | 459 | ||
| TREATMENT PRINCIPLES | 459 | ||
| PRINCIPLES OF CHEMOTHERAPY | 460 | ||
| PRINCIPLES OF RADIOTHERAPY | 461 | ||
| TREATMENT RESPONSIVENESS | 462 | ||
| PERSONALIZED MEDICINE | 462 | ||
| MOLECULAR TARGETED THERAPY | 462 | ||
| FAMILIAL CANCERS AND CANCER GENETICS | 463 | ||
| ONCOLOGICAL EMERGENCIES | 463 | ||
| TUMOR MARKERS IN SERUM | 465 | ||
| PARANEOPLASTIC SYNDROME | 466 | ||
| CANCER WITH UNKNOWN PRIMARY (CUP) | 466 | ||
| LUNG CANCER | 467 | ||
| RENAL CANCER | 469 | ||
| TUMORS OF THE PELVIS, URETER AND BLADDER | 469 | ||
| PROSTATE CANCER | 470 | ||
| TESTIS CANCER | 471 | ||
| HEAD AND NECK CANCER | 473 | ||
| ESOPHAGEAL CANCER | 473 | ||
| GASTRIC CANCER | 474 | ||
| COLORECTAL CANCER | 475 | ||
| PANCREATIC CANCER | 477 | ||
| HEPATOCELLULAR CARCINOMA (HCC) | 478 | ||
| BRAIN TUMORS | 479 | ||
| LYMPHOMA | 480 | ||
| MELANOMA | 480 | ||
| SARCOMA | 481 | ||
| BREAST CANCER | 482 | ||
| OVARIAN CANCER | 484 | ||
| ENDOMETRIAL CANCER | 486 | ||
| SELF- ASSESSMENT QUESTIONS | 487 | ||
| CHAPTER 16. PALLIATIVE MEDICINE | 489 | ||
| PAIN | 490 | ||
| MUCOSITIS | 492 | ||
| FATIGUE | 493 | ||
| NAUSEA AND VOMITING | 493 | ||
| CACHEXIA AND ANOREXIA | 496 | ||
| DYSPNEA | 497 | ||
| CONSTIPATION | 498 | ||
| DELIRIUM | 498 | ||
| INSOMNIA | 499 | ||
| SELF-ASSESSMENT QUESTIONS | 501 | ||
| CHAPTER 17. IMMUNOLOGY | 503 | ||
| KEY CONCEPTS IN IMMUNOBIOLOGY | 504 | ||
| ALLERGIC DISEASE | 509 | ||
| EOSINOPHILIA | 521 | ||
| MAST CELL DISORDERS | 522 | ||
| SYSTEMIC AUTOIMMUNE DISEASE | 522 | ||
| PRIMARY VASCULITIS | 534 | ||
| AUTOINFLAMMATORY DISORDERS | 540 | ||
| IMMUNODEFICIENCY | 541 | ||
| HIV/AIDS | 544 | ||
| SELF-ASSESSMENT QUESTIONS | 551 | ||
| CHAPTER 18. MUSCULOSKELETAL MEDICINE | 557 | ||
| AN APPROACH TO A PATIENT WITH PAINFUL JOINTS | 558 | ||
| RHEUMATOID ARTHRITIS (RA) | 560 | ||
| SPONDYLOARTHROPATHIES | 565 | ||
| RELAPSING POLYCHONDRITIS (RP) | 574 | ||
| OSTEOARTHRITIS (OA) | 574 | ||
| GENETIC CONNECTIVE TISSUE DISORDERS | 578 | ||
| PAINFUL SHOULDERS | 578 | ||
| TENNIS ELBOW AND GOLFER’S ELBOW | 581 | ||
| PLANTAR FASCIITIS | 581 | ||
| FIBROMYALGIA | 582 | ||
| SEPTIC ARTHRITIS | 584 | ||
| ACUTE LOW BACK PAIN | 585 | ||
| CHRONIC LOW BACK PAIN | 587 | ||
| SELF- ASSESSMENT QUESTIONS | 589 | ||
| CHAPTER 19. NEUROLOGY | 593 | ||
| DISORDERS OF CONSCIOUSNESS | 594 | ||
| HEADACHE | 596 | ||
| STROKE | 602 | ||
| INTRACEREBRAL HEMORRHAGE | 606 | ||
| SUBARACHNOID HEMORRHAGE (SAH) | 606 | ||
| TRANSIENT ISCHEMIC ATTACK (TIA) | 606 | ||
| DEMENTIA | 607 | ||
| SEIZURES AND THE EPILEPSIES | 611 | ||
| BALANCE, DIZZINESS AND VERTIGO | 618 | ||
| MOVEMENT DISORDERS | 623 | ||
| MULTIPLE SCLEROSIS AND CNS INFLAMMATION | 630 | ||
| NEUROLOGICAL MANIFESTATIONS OF SARCOIDOSIS AND BEHÇET’S DISEASE | 635 | ||
| NEUROMUSCULAR DISEASE | 635 | ||
| NEUROMUSCULAR DISORDERS | 639 | ||
| SELF-ASSESSMENT QUESTIONS | 646 | ||
| CHAPTER 20. PSYCHIATRY FOR THE INTERNIST | 651 | ||
| DEPRESSION | 651 | ||
| ANXIETY DISORDERS | 652 | ||
| POST-TRAUMATIC STRESS DISORDER (PTSD) | 652 | ||
| SOMATIZATION | 653 | ||
| EATING DISORDERS | 653 | ||
| SUICIDE AND DELIBERATE SELF-HARM | 654 | ||
| PSYCHOTROPIC AGENTS | 655 | ||
| SELF-ASSESSMENT QUESTIONS | 658 | ||
| CHAPTER 21. CLINICAL INFECTIOUS DISEASES | 659 | ||
| CLINICAL APPROACH TO INFECTIOUS DISEASES | 660 | ||
| DIAGNOSTICS IN INFECTIOUS DISEASES | 661 | ||
| SELECTED COMMON CLINICALLY IMPORTANT ORGANISMS | 662 | ||
| ANTI-INFECTIVE TREATMENT | 668 | ||
| ANTI-INFECTIVE AGENTS | 671 | ||
| SPECIFIC SYNDROMES | 681 | ||
| INFECTIONS IN SPECIAL HOSTS AND POPULATIONS | 685 | ||
| SYSTEMIC VIRAL INFECTIONS | 692 | ||
| INFECTION PREVENTIONAND CONTROL | 696 | ||
| SELF-ASSESSMENT QUESTIONS | 698 | ||
| CHAPTER 22. IMMUNIZATION | 701 | ||
| GENERAL PRINCIPLES | 701 | ||
| IMMUNIZING AGENTS | 702 | ||
| FACTORS AFFECTING IMMUNOGENICITY | 703 | ||
| BOOSTER DOSES | 704 | ||
| IMMUNIZATION IN SPECIFIC POPULATIONS | 704 | ||
| POST-EXPOSURE PROPHYLAXIS (PEP) | 707 | ||
| ROUTINE IMMUNIZATION OF ADULTS | 707 | ||
| SELF-ASSESSMENT QUESTIONS | 711 | ||
| CHAPTER 23. DERMATOLOGY FOR THE PHYSICIAN | 715 | ||
| ACNE | 715 | ||
| AUTOIMMUNE DISEASES OF THE SKIN | 715 | ||
| SKIN PROBLEMS ASSOCIATED WITH UNDERLYING SYSTEMIC DISEASE | 719 | ||
| GENETIC OR CONGENITAL SKIN DISEASES | 722 | ||
| SKIN DISEASE ASSOCIATED WITH MALIGNANCY | 723 | ||
| SELF-ASSESSMENT QUESTIONS | 725 | ||
| CHAPTER 24. MEDICAL OPHTHALMOLOGY | 727 | ||
| INTRODUCTIONE | 727 | ||
| OCULAR HISTORY | 728 | ||
| OCULAR EXAMINATION | 728 | ||
| PATHOLOGICAL CONDITIONS | 732 | ||
| UVEITIS | 735 | ||
| RETINITIS | 736 | ||
| SCLERITIS AND SCLEROUVEITIS | 736 | ||
| THYROID-RELATED ORBITOPATHY | 736 | ||
| DRY EYE | 737 | ||
| NEOPLASIA AND THE EYE | 737 | ||
| NEURO-OPHTHALMOLOGY | 738 | ||
| PHAKOMATOSES | 739 | ||
| OCULAR EFFECTS OF SYSTEMIC MEDICATION | 739 | ||
| SELF-ASSESSMENT QUESTIONS | 741 | ||
| CHAPTER 25. WOMEN’S HEALTH FOR THE PHYSICIAN | 743 | ||
| INFERTILITY | 743 | ||
| CONTRACEPTION | 745 | ||
| MENOPAUSAL SYMPTOMS | 748 | ||
| PREMENSTRUAL SYNDROME | 749 | ||
| ABNORMAL UTERINE BLEEDING | 749 | ||
| DYSMENORRHEA | 750 | ||
| VULVAR CONDITIONS | 750 | ||
| SEXUALLY TRANSMITTED INFECTIONS (STIs) | 753 | ||
| PELVIC INFLAMMATORY DISEASE (PID) | 754 | ||
| SEXUAL PROBLEMS | 755 | ||
| SELF-ASSESSMENT QUES | 757 | ||
| CHAPTER 26. OBSTETRIC MEDICINE | 759 | ||
| GENERAL PRINCIPLES OF MEDICAL OBSTETRIC CARE | 760 | ||
| DIABETES IN PREGNANCY | 760 | ||
| HYPERTENSION IN PREGNANCY | 763 | ||
| RESPIRATORY DISEASE IN PREGNANCY | 764 | ||
| VENOUS THROMBOEMBOLISM (VTE) IN PREGNANCY | 766 | ||
| THYROID DISORDERS IN PREGNANCY | 766 | ||
| COMMON GASTROENTEROLOGICAL AND LIVER DISORDERS IN PREGNANCY | 767 | ||
| VIRAL INFECTION IN PREGNANCY | 769 | ||
| IMMUNOLOGICAL AND HEMATOLOGICAL DISEASE IN PREGNANCY | 770 | ||
| CARDIAC DISEASE IN PREGNANCY | 771 | ||
| OBESITY IN PREGNANCY | 773 | ||
| NEUROLOGICAL CONDITIONS IN PREGNANCY | 773 | ||
| SELF-ASSESSMENT QUESTIONS | 774 | ||
| CHAPTER 27. GERIATRIC MEDICINE | 777 | ||
| INTRODUCTION | 777 | ||
| EPIDEMIOLOGY OF AGING | 778 | ||
| AGING AND DISEASE | 778 | ||
| PHYSIOLOGY OF AGING | 779 | ||
| PATHOLOGY: DISEASE IN OLDER PEOPLE | 780 | ||
| THE GIANTS OF GERIATRICS | 780 | ||
| ELDER ABUSE | 786 | ||
| OSTEOPOROSIS | 786 | ||
| COMPREHENSIVE GERIATRIC ASSESSMENT | 786 | ||
| HEALTHY AGING | 787 | ||
| FACING THE INEVITABLE WITH DIGNITY | 788 | ||
| SELF-ASSESSMENT QUESTIONS | 789 | ||
| INDEX | 791 |